Compare CERT & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CERT | IART |
|---|---|---|
| Founded | 2008 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 860.9M | 823.8M |
| IPO Year | 2020 | 1996 |
| Metric | CERT | IART |
|---|---|---|
| Price | $6.33 | $13.93 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 7 |
| Target Price | $11.67 | ★ $14.33 |
| AVG Volume (30 Days) | ★ 2.5M | 954.1K |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 87.50 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $418,838,000.00 | N/A |
| Revenue This Year | $4.18 | $4.39 |
| Revenue Next Year | $5.39 | $3.40 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 8.75 | N/A |
| 52 Week Low | $5.19 | $8.70 |
| 52 Week High | $13.88 | $16.42 |
| Indicator | CERT | IART |
|---|---|---|
| Relative Strength Index (RSI) | 55.41 | 72.93 |
| Support Level | $5.93 | $12.90 |
| Resistance Level | $6.48 | $14.38 |
| Average True Range (ATR) | 0.28 | 0.71 |
| MACD | 0.04 | 0.37 |
| Stochastic Oscillator | 76.87 | 89.60 |
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.